Clinical Trials Directory

Trials / Conditions / Thymus Neoplasms

Thymus Neoplasms

10 registered clinical trials studyying Thymus Neoplasms — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingAnti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumo
NCT06885697
National Cancer Institute (NCI)Phase 1
Active Not RecruitingAdjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection
NCT06189183
Cancer Institute and Hospital, Chinese Academy of Medical SciencesN/A
RecruitingEfficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tu
NCT05918302
Grupo Espanol de Tumores NeuroendocrinosPhase 3
TerminatedContinuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With
NCT02859415
National Cancer Institute (NCI)Phase 1 / Phase 2
RecruitingStudy on Proton Radiotherapy of Thymic Malignancies
NCT04822077
Ass. Prof. Jan NymanN/A
UnknownPembrolizumab and Epacadostat in Patients With Thymic Carcinoma
NCT02364076
Georgetown UniversityPhase 2
CompletedSunitinib for Advanced Thymus Cancer Following Earlier Treatment
NCT01621568
National Cancer Institute (NCI)Phase 2
Withdrawn18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma
NCT01610544
National Cancer Institute (NCI)Phase 2
CompletedEsophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies
NCT00921739
Duke UniversityPhase 1
CompletedThoracic OncoGeriatric Assessment (TOGA) Trials
NCT00591981
University of Wisconsin, Madison—